Andrew Jones

Dr. Jones leads a lab at Miami University-Ohio focusing on the biosynthesis of various psychedelics and psychedelic-inspired compounds. He has mentored over 50 research trainees and published over 35 peer reviewed papers.

Miami University
Wednesday
May 07
Synthesizing Psychedelics: Unpacking the Options for Psychedelics Production
3:30 PM

-

4:15 PM

In this session we will explore the many methods of producing psychedelic and psychedelic-inspired compounds for clinical applications. The discussion will center around the pros and cons of a synthetic biology-based approach as compared with chemical synthetic and natural product extraction-based approaches. We will discuss topics such as environmental sustainability, scalability, technology transfer, and cost, as well as how future disrupting technologies could impact this emerging field.

Other Speakers

Social Media

Other

Copyright SynBioBeta 2025

Social Media

Other

Copyright SynBioBeta 2025

Social Media

Other

Copyright SynBioBeta 2025